Innovations

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway

By 91 views
0
Glass laboratory flasks on light table

A new research paper titled “MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway” has been published in Oncotarget.

New study illuminates why cancers caused by BRCA mutations recur

Previous article

Global SARS-CoV-2 infection rates likely to be higher than previously reported

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations